Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney
Cancer Biomarkers, 06/08/2012
Yokomizo A et al. – The FN1 is considered to be a promising biomarker candidate for clear cell renal cell carcinoma (RCC). Furthermore, Amplified Luminescent Proximity Homogeneous Assay (AlphaLISA) is an alternate to the conventional enzyme–linked immunosorbent assay and should prove useful for the rapid validation of biomarker candidates.